ciltacabtagene autoleucel
janssen
['carvykti', 'rova', 'car-t', 'biotec']
spoke w/legend's ceo on the sidelines of #asco22 about carvykti if the car-t gets a second approval next year, ying huang thinks his biotech and partner j&amp;j can reach as many as 80,000 patients instead of current 22,000 
covering the science, people, $ & biotechs behind new meds @Endpts | Tips? klahucik@endpointsnews.com | asking Q's, jogging 26.2 | ?? ?? ?? | he/him ??????